A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout

Overview of attention for article published in Frontiers in immunology, February 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 57,681 followers.

RT @manuelmuro5: Interesante. SLC3037, un inhibidor de NLRP3 que bloquea la unión de NEK7 a NLRP3, podría ser novedoso contra enfermedades…

RT @manuelmuro5: Interesante. SLC3037, un inhibidor de NLRP3 que bloquea la unión de NEK7 a NLRP3, podría ser novedoso contra enfermedades…

RT @FrontImmunol: New Research: A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout: Background Since NEK…

RT @manuelmuro5: Interesante. SLC3037, un inhibidor de NLRP3 que bloquea la unión de NEK7 a NLRP3, podría ser novedoso contra enfermedades…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.